Prognostic Stage 2 Breast Cancer AJCC v8 Active Not Recruiting Phase 0 Trials for Durvalumab (DB11714)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)Active Not Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs